The Surprising Ozempic Benefits You Didn't Know

About this video

Yurth explains what she means by microdosing a GLP-1 agonist: using the medicine at a level intended to capture health benefits without triggering weight loss or significant side effects, rather than following a standard weight-loss approach. She argues these medicines may be among the most important longevity tools available, attributing to them claimed benefits for cognition and neuroprotection, cardiovascular, liver, and kidney health, muscle preservation, and conversion of white fat toward a more metabolically active form. She emphasizes that the appropriate level varies by person and should be judged by response — benefits sought, appetite, weight change, and side effects — rather than by a universal target.

Key takeaways

• Microdosing here means benefits without weight loss, in Yurth’s definition
• Judge the level by individual response, not by a one-size-fits-all target
• Yurth frames GLP-1 benefits as extending well beyond weight and blood sugar
• Brain health is presented as a reason some non-overweight patients consider this approach
• Back off, in her model, when weight loss or side effects appear

Episode details: published February 19, 2025 · 1.1K views · 1:30 long. Summary written by Self Growth Videos from the episode itself. The longevity and peptide concepts described are Dr. Elizabeth Yurth’s, presented for education — not medical advice. Consult a qualified professional before changing your own health practices. Disclosure: Dr. Yurth is co-founder and Chief Medical Officer of the Boulder Longevity Institute, a clinic, and BLI Academy sells clinician education.

← Previous: Post-Surgery Recovery Hacks You NEED to Know! · Next: Q&A Highlights: February 2025 →

All Dr. Elizabeth Yurth videos · Dr. Elizabeth Yurth profile · Boulder Longevity Institute (official site)